Draft rule proposes CCTV recording of prescription medicine sales
The Union health ministry has proposed a draft amendment to the Drugs Rules, 1945, requiring sales of prescription medicines at medical stores to be recorded on CCTV, with footage kept at least three months. It targets Schedule H, H1 and X drugs; except wholesale dealing, all supply at licensed premises would be under CCTV. The Drugs Technical Advisory Board recommended approval. Objections are invited. AIOCD president J S Shinde said compliance could cost small chemists Rs 50,000-1 lakh.
Source
Times of India — Top · read the original report ↗
Desk check · compared with the source
What the desk checked (5)
- A draft amendment to the Drugs Rules, 1945 proposes CCTV recording of prescription medicine sales, with footage retained at least three months. — Attributed to a draft amendment proposed by the Union health ministry; figure appears in source.
- The requirement targets Schedule H, H1 and X drugs, and covers all supply except wholesale dealing at licensed premises. — Attributed to the draft as described in the source.
- The proposal was considered by the Drugs Consultative Committee and recommended for approval by the Drugs Technical Advisory Board. — Attributed to the health ministry in the source.
- CCTV compliance could cost small and medium chemists Rs 50,000-1 lakh or more. — Direct quote attributed to J S Shinde, president, All India Organisation of Chemists & Druggists; an estimate, not verified.
- The rule will take effect from a date specified by government after final publication in the Official Gazette. — Stated in the draft as reported; timeline not fixed in source.
Analysts’ view opinion
This is less a crackdown than a design fix: it hands regulators verifiable evidence on whether Schedule H, H1 and X medicines were actually sold against a prescription. Until now enforcement leaned on prescription registers and paper records that can be reconstructed after the fact; CCTV footage closes that gap. But the cost and upkeep sit entirely with the retail chemist while the benefit accrues to public health — that asymmetry is the draft's central balancing problem.
- The primary beneficiaries are patients and the drug regulatory machinery, while the compliance burden falls on licensed retail pharmacies.
- Exempting wholesale trade suggests a targeted approach, focused on the final counter where over-the-counter dispensing of prescription drugs is most likely.
- Three months of retention looks like a workable compromise, but who may access the footage and how patient privacy is protected is not spelt out in what the story reports.
- The AIOCD's point on Rs 50,000-1 lakh costs plus unreliable power and connectivity highlights the classic difficulty of a uniform rule in rural settings.
- Routing the proposal through the Drugs Consultative Committee and the Drugs Technical Advisory Board is procedurally sound, and the objections window leaves room for phasing or relief for smaller stores.
What to watch — Watch whether the final gazette notification adds phased rollout, exemptions or support for small chemists, and explicit rules on footage access and privacy.
This remains a draft — the enforcement date, who bears the cost, penalties for non-compliance and privacy safeguards are not established by this story.
Deep dive
Research brief · 8 facts · 4 dates · exam-readyThe brief
Context
The Union health ministry has floated a draft amendment to the Drugs Rules, 1945, that would make CCTV recording mandatory for the sale of prescription medicines at licensed retail premises. The proposal targets drugs listed under Schedule H, H1 and X, which cannot legally be sold without a valid prescription. Footage would have to be preserved for at least three months so regulators can verify transactions if concerns arise. The proposal moved through the Drugs Consultative Committee and the Drugs Technical Advisory Board, which recommended approval, and the ministry has now invited objections and suggestions.
Key facts
- Draft amendment to the Drugs Rules, 1945, proposes that sale of prescription medicines at medical stores be recorded on CCTV.
- CCTV footage would have to be retained for at least three months.
- The rule targets oversight of Schedule H, H1 and X drugs, which cannot be sold without a valid prescription.
- Except wholesale dealing, all drug supply at licensed premises would be under the CCTV system.
- The proposal was first considered by the Drugs Consultative Committee and then circulated to the Drugs Technical Advisory Board.
- The Drugs Technical Advisory Board recommended approval of the proposal, according to the health ministry.
- The rule will come into force from a date specified by the government when the amendment is finally published in the Official Gazette.
- AIOCD president J S Shinde said compliance could cost small and medium chemists Rs 50,000-1 lakh or more, apart from ongoing maintenance.
Timeline
- First stage (date not stated in the source)Proposal considered by the Drugs Consultative Committee.
- Next stage (date not stated in the source)Proposal circulated to the Drugs Technical Advisory Board, which recommended approval.
- Current stageHealth ministry issues draft amendment and invites objections and suggestions from stakeholders and the public.
- FutureRule to come into force from a date specified by the government on final publication in the Official Gazette.
Who has a stake
- Union health ministry — Proposes the amendment to tighten oversight of prescription-only drug sales and enable verification of transactions.
- Patients / public — Gain an additional safeguard against medicines sold without prescriptions or accessed through illegal channels.
- Retail chemists and medical stores — Would bear installation and maintenance costs; small and medium chemists face Rs 50,000-1 lakh or more per the AIOCD.
- All India Organisation of Chemists & Druggists (AIOCD) — Seeks a practical and proportionate approach, citing cost and rural power/internet constraints.
- Drugs Technical Advisory Board and Drugs Consultative Committee — Statutory advisory bodies that vetted the proposal; DTAB recommended its approval.
- Drug regulators / enforcement authorities — Would be able to check recorded transactions when concerns are raised.
Why it matters
Prescription-only drugs, including antibiotics and habit-forming medicines under Schedules H, H1 and X, are widely sold over the counter, and recorded evidence of each sale would give regulators a verifiable trail. But the compliance burden falls on lakhs of small retailers, and the AIOCD warns that a uniform mandate is hard to implement where power and internet supply are unreliable. The final shape of the rule will test how India balances drug-safety enforcement against the capacity of small businesses.
UPSC angle
Prelims pointers
- Drugs Rules, 1945 is the subordinate legislation being amended by the draft rule.
- Schedule H, H1 and X drugs cannot be sold without a valid prescription.
- Draft rule requires CCTV footage of prescription drug sales to be kept for at least three months.
- Drugs Technical Advisory Board (DTAB) recommended approval; the Drugs Consultative Committee considered it first.
- Wholesale dealing is excluded from the proposed CCTV requirement.
- The amendment takes effect from a date notified in the Official Gazette.
Mains framing
India's problem of prescription medicines being dispensed without a valid prescription, or diverted through illegal channels, has long strained drug regulation, particularly for Schedule H, H1 and X categories that include prescription-only and habit-forming drugs. The health ministry's draft amendment to the Drugs Rules, 1945, responds by creating a technological audit trail: CCTV coverage of all supply at licensed premises except wholesale dealing, with footage preserved for a minimum of three months so regulators can inspect transactions when concerns are raised. The proposal has institutional backing, having been considered by the Drugs Consultative Committee and recommended for approval by the Drugs Technical Advisory Board, and is now open to objections and suggestions. The counter-argument, articulated by the All India Organisation of Chemists & Druggists, is one of proportionality and capacity: a uniform mandate could cost small and medium chemists Rs 50,000-1 lakh or more plus maintenance, and is hard to operationalise in rural areas with unreliable power and internet. A workable way forward, consistent with the stakeholder consultation now underway, would involve calibrating requirements to the size and location of the outlet and clarifying footage-storage obligations, so that enforcement gains do not translate into the exit of small retailers or reduced medicine access.
Key terms
- Drugs Rules, 1945
- The rules governing manufacture, sale and distribution of drugs in India, now proposed to be amended to mandate CCTV at medical stores.
- Schedule H and H1 drugs
- Categories of drugs that cannot be sold without a valid prescription; H1 covers medicines needing stricter record-keeping.
- Schedule X drugs
- Prescription-only drugs subject to the tightest sale and record controls under the Drugs Rules.
- Drugs Technical Advisory Board (DTAB)
- Top technical advisory body on drug matters; it recommended approval of the CCTV proposal.
- Drugs Consultative Committee (DCC)
- Advisory body that first considered the proposal before it went to DTAB.
- AIOCD
- All India Organisation of Chemists & Druggists, the retail pharmacy body that flagged cost and connectivity concerns.
Practice questions
- The draft amendment to the Drugs Rules, 1945 mandating CCTV recording of prescription drug sales seeks to curb over-the-counter dispensing. Examine its likely benefits and the implementation challenges for small retailers.
- Discuss the roles of the Drugs Technical Advisory Board and the Drugs Consultative Committee in India's drug regulatory framework, with reference to the proposed CCTV rule.
- Surveillance-based compliance tools can strengthen enforcement but raise cost and feasibility concerns. Critically evaluate this in the context of regulating Schedule H, H1 and X drug sales in India.
Grounded only in the source report — figures and dates are the source's, not inferred.